PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design and UCB, a global biopharma company focusing on neurology and immunology, today announced a software ...

Retrosynthesis aims to predict a set of reactants for producing given molecules, which plays a significant part in the biochemistry field, such as molecular pathway design and drug discovery. Most ...

PARIS--(BUSINESS WIRE)--Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a collaboration with Galapagos, a leading global biopharmaceutical company focused ...

Synthetic route design remains a critical bottleneck in small‑molecule drug discovery, especially as teams juggle complex targets, aggressive timelines, and sustainability expectations.

Uniting advanced technology with CAS's unmatched collection of chemical reaction data increases efficiency of chemical synthesis planning COLUMBUS, Ohio, July 1, 2019 /CNW/ -- CAS, a division of the ...

Expert-coded by chemists and engineered by computer scientists, SYNTHIA™ Retrosynthesis Software allows scientists to quickly discover novel pathways for new and published target molecules. Developed ...